Sign In
Buy HALO
$69.82
+3.54 (+5.34%)
At Close: Jun 03, 2026
BidaskClub Upgrades Halozyme Therapeutics (NASDAQ:HALO) to "Strong-Buy"
09:04am, Monday, 27'th Apr 2020
BidaskClub upgraded shares of Halozyme Therapeutics (NASDAQ:HALO) from a buy rating to a strong-buy rating in a report published on Thursday, BidAskClub reports. Several other analysts also recently c
Halozyme Therapeutics Inc:
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the submission of a New Drug Application (NDA) to the Ministry of Health, Labour and Welfare (MHLW) by Janssen Pharmaceutical K.K. (Janssen)
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs April 23.)
Arcturus Therapeutics Ltd...
Stocks That Hit 52-Week Highs On Thursday
02:41pm, Thursday, 23'rd Apr 2020
During Thursday's morning trading, these companies set new 52-week highs.
Noteworthy Points:
Johnson & Johnson (NYSE: JNJ) was the largest company by market cap...
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Expected to Post Quarterly Sales of $39.35 Million
05:34am, Thursday, 23'rd Apr 2020
Equities analysts expect Halozyme Therapeutics, Inc. (NASDAQ:HALO) to report sales of $39.35 million for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Halozyme Ther
Scientists Have Discovered Supernovas That Can Kick Stars Outside Its Halo
05:55am, Tuesday, 21'st Apr 2020
Will our Sun be kicked off as well?
Bank of America Corp DE Boosts Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
09:08am, Wednesday, 15'th Apr 2020
Bank of America Corp DE increased its stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) by 0.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission
What You Must Know About Halozyme Therapeutics, Inc.'s (NASDAQ:HALO) Beta Value
12:44pm, Monday, 13'th Apr 2020
Anyone researching Halozyme Therapeutics, Inc. (NASDAQ:HALO) might want to consider the historical volatility of the...
Geode Capital Management LLC Boosts Stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
10:10am, Saturday, 11'th Apr 2020
Geode Capital Management LLC raised its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO) by 3.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Co
Is Halozyme Therapeutics, Inc. (NASDAQ:HALO) Overpaying Its CEO?
11:01am, Friday, 10'th Apr 2020
Helen Torley became the CEO of Halozyme Therapeutics, Inc. (NASDAQ:HALO) in 2014. First, this article will compare CEO...
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Purchased by Bank of New York Mellon Corp
08:52am, Friday, 10'th Apr 2020
Bank of New York Mellon Corp raised its stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO) by 0.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange C
